Out of a population of 150 LifeMD patients, on average, patients on Triple Therapy lost 7 pounds within the first three months of treatment.
Mechanistically, these agents inhibit the NLRP3 inflammasome and downregulate proinflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor- (TNF-), and C-reactive protein (CRP), thereby alleviating systemic inflammation that sustains long-COVID symptoms [38, 39]
SR: Writing review & editing, Writing original draft
Additional reasons for deferral include: Diabetes-related complications affecting the heart, kidneys, eyes, peripheral nerves, or circulation Recent hospital admission or significant illness Unstable diabetes control or recent treatment changes Concurrent serious medical conditions Donors must also meet standard eligibility criteria regarding age (17 years or older